Mass shootings are rare events with causes that are not well understood, particularly, the extent to which they are responses to social and economic circumstances. The COVID-19 pandemic imposed sudden and additional psychological and financial strains across society through fear of death, social isolation, economic hardship, and general uncertainty. Although several studies have examined how gun violence, homicides, and other crimes have responded to the pandemic, these analyses have focused on small groups of cities and have not considered mass shootings, which are an extreme form of violence whose causes may not be the same.1- 4 This cross-sectional study analyzes changes in mass shootings in the US during the COVID-19 pandemic.
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: July 13, 2021.
Published: September 16, 2021. doi:10.1001/jamanetworkopen.2021.25388
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Peña PA et al. JAMA Network Open.
Corresponding Author: Anupam Jena, MD, PhD, Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115 (firstname.lastname@example.org).
Author Contributions: Dr Peña had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Peña.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: All authors.
Conflict of Interest Disclosures: Dr Jena reports receiving consulting fees from Bioverativ, Merck/Sharp/Dohme, Janssen, Edwards Life Sciences, Novartis, Amgen, Eisai, Otsuka Pharmaceuticals, Vertex Pharmaceuticals, Celgene, Sanofi Aventis, Precision Health Economics, and Analysis Group outside the submitted work. Dr Jena reported receiving personal fees from Bioverativ, Merck, Janssen, Edwards Life Sciences, Novartis, Amgen, Vertex, Celgene, Sanofi Aventis, Precision Health Economics, and Analysis Group outside the submitted work. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.